Drugs not approved by the FDA are allowed to be prescribed under certain conditions

the verdict

SUPPORTED

the evidence backs this

Recorded sources

3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that drugs not approved by the FDA are allowed to be prescribed under certain conditions?

Yes. Unapproved or investigational drugs can be legally prescribed to patients under specific regulatory frameworks, such as expanded access or compassionate use programs. Multiple studies confirm that these mechanisms provide legal pathways for treating individuals with serious conditions when approved options are unavailable.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked 5 Aug 2026

The analysis

The claim states that drugs not approved by the FDA (or equivalent agencies) are allowed to be prescribed under certain conditions. Retrieved papers discuss expanded access, compassionate use, and alternative regulatory frameworks (such as in Papers 1, 5, and 6) that specifically provide legal mechanisms for prescribing unapproved drugs under defined conditions. Therefore, the claim is fully supported by the literature.

Evidence for · 3

Applying real-world data from expanded-access (“compassionate use”) patients to drug development

2023

Get citation

Wasser, J. S. & Greenblatt, D. J. (2023). Applying real-world data from expanded-access (“compassionate use”) patients to drug development. doi.org. https://doi.org/10.1017/cts.2023.606

See more details

More for · 2

Early access disparities in innovative therapies across the US, EU, China, and Japan.

2025

Get citation

S, A., M, G., & H, S. (2025). Early access disparities in innovative therapies across the US, EU, China, and Japan.. doi.org. https://doi.org/10.3389/fmed.2025.1642882

Disparities in access to gene therapy in the European Union: ethical and regulatory challenges.

2025

Get citation

M, R., R, M., P, L., E, V. S., I, H., & P, B. (2025). Disparities in access to gene therapy in the European Union: ethical and regulatory challenges.. doi.org. https://doi.org/10.1093/jlb/lsaf018

Related receipts

Is it true that certain pharmaceutical drugs are prescribed more frequently to males than to females? SUPPORTED related question, same topic
Is it true that as of 2026, no drug has been approved by the US FDA specifically to treat vascular dementia? PARTIAL LEAN related question, same topic

Receipt History

first checked05 Aug 2026

judged → SUPPORTED · 8105 Aug 2026

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work